Nationwide Surveillance and Molecular Characterization of Critically Drug-Resistant Gram-Negative Bacteria: Results of the Research University Network Thailand Study
Overview
Authors
Affiliations
A large-scale surveillance is an important measure to monitor the regional spread of antimicrobial resistance. We prospectively studied the prevalence and molecular characteristics of clinically important Gram-negative bacilli, including Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii complex (ABC), and Pseudomonas aeruginosa, from blood, respiratory tract, urine, and sterile sites at 47 hospitals across Thailand. Among 187,619 isolates, 93,810 isolates (50.0%) were critically drug resistant, of which 12,915 isolates (13.8%) were randomly selected for molecular characterization. was most commonly isolated from all specimens, except the respiratory tract, in which ABC was predominant. Prevalence of extended-spectrum cephalosporin resistance (ESCR) was higher in (42.5%) than K. pneumoniae (32.0%), but carbapenem-resistant (CR)-K. pneumoniae (17.2%) was 4.5-fold higher than CR- (3.8%). The majority of ESCR/CR- and K. pneumoniae isolates carried (64.6% to 82.1%). and were the most prevalent carbapenemase genes in CR-/CR-K. pneumoniae (74.9%/52.9% and 22.4%/54.1%, respectively). In addition, 12.9%/23.0% of CR-/CR-K. pneumoniae cocarried and Among ABC isolates, 41.9% were extensively drug resistant (XDR) and 35.7% were multidrug resistant (MDR), while P. aeruginosa showed XDR/MDR at 6.3%/16.5%. A. baumannii was the most common species among ABC isolates. The major carbapenemase gene in MDR-A. baumannii/XDR-A. baumannii was (85.8%/93.0%), which had much higher rates than other ABC species. , , , and were also detected in ABC at lower rates. The most common carbapenemase gene in MDR/XDR-P. aeruginosa was (29.0%/30.6%), followed by (9.5%/25.3%). The findings reiterate an alarming situation of drug resistance that requires serious control measures.
Rongrungruang Y, Plongla R, Pleumkanitkul S, Hantrakun V, Khawcharoenporn T Infect Drug Resist. 2025; 18:351-361.
PMID: 39867290 PMC: 11761138. DOI: 10.2147/IDR.S492299.
Beig M, Parvizi E, Navidifar T, Bostanghadiri N, Mofid M, Golab N PLoS One. 2024; 19(12):e0311124.
PMID: 39680587 PMC: 11649148. DOI: 10.1371/journal.pone.0311124.
Tancharoen L, Srisomnuek A, Tiengrim S, Thamthaweechok N, Tangkorskul T, Thamlikitkul V Antibiotics (Basel). 2024; 13(8).
PMID: 39200081 PMC: 11351571. DOI: 10.3390/antibiotics13080781.
Shrestha R, Shrestha D, Sah A, Thapa A, Shrestha N, Raya G JAC Antimicrob Resist. 2024; 6(2):dlae035.
PMID: 38476771 PMC: 10928669. DOI: 10.1093/jacamr/dlae035.
Chirabhundhu N, Luk-In S, Phuadraksa T, Wichit S, Chatsuwan T, Wannigama D Sci Rep. 2024; 14(1):5215.
PMID: 38433246 PMC: 10909888. DOI: 10.1038/s41598-024-55705-2.